• 4th Global Conference on

    Virology and Vaccines

    August 16-18, 2018
    London, UK

Featured Speakers

Click on image to view speaker details

About the Event

What is Virology & Vaccines

Welcome to Global conference on Virology and Vaccines is going to be conducted in London, UK on August 16-18 of 2018. This conference invites connoisseurs from all pre-eminent universities, research institutions, microbiologists, virologists and vaccines diagnostic companies to share their research papers on all aspects of this rapidly augmenting field and emblazoning the recent advancements and technologies being currently used and the ones being developed on futuristic technologies for further research on viruses and vaccines. It helps people who are pursuing and also those who are conducting researches on this subject to get compacted with the delegates and scholars with deep rooted knowledge and experience which ultimately prove beneficial to the concerned individuals. The scientific program paves a way to gather visionaries through the research talks and presentations and put forward many thought provoking strategies. The scientific program will focus on current advances in the research on virology and Vaccination with particular focus on its role in maintaining health and preventing diseases.

Organizing Committee

Click on the image to view biography

Professor Peter Timms

University of the Sunshine Coast, Australia.

Professor Timms is a nationally and internationally renowned microbiologist with specific expertise in the area of Chlamydia. His laboratory is acknowledged as the leading Australian laboratory and one of the leading groups internationally working on all aspects of chlamydial infections

AE Aboulata

Plant Path. Res. Inst., Egypt

Dr Aboul-Ata Elnady ABOUL-ATA, Professor Dr. of Plantvirology, who was born on Mar.22nd 1948 in Sharkia, Egypt, is the president of ArSV (Arab Society for Virology) in 2013 for 3 years. He was formerly Department Head of Plant Virus and Phytoplasma Research, Plant Pathology Research Institute at Agricultural Research Center, Giza, Egypt for 3 years (2003-2006), and Head of Molecular laboratoryat Plant Virus and Phytoplasma Res. from Sep. 2005 up to now. In 2007 he has been awarded committee membership of Egyptian Society of Advanced Material and NanoTechnology.He is being a committee-member of Egyptian Society of Virology(ESV) since initiation in 2001 up to now. He is the General Secretary for ESV since 2014 for 3-year period. He is being member of the Molecular Virology Group at the University of Kentucky, USA, American Phytopathological Society,

Dimiter S Dimitrov

National Cancer Institute (NCI) of the National Institutes of Health (NIH), USA.

Dr. Dimitrov graduated and completed his PhD at the University of Sofia, Sofia, Bulgaria, and thereafter he worked in the Bulgarian Academy of Sciences where he defended his ScD and was Professor of Biophysics until he joined the National Cancer Institute (NCI) of the National Institutes of Health (NIH), USA, in 1990. There he was tenured as Senior Investigator and appointed at the Senior Biomedical Research Service. His research group includes molecular biologists who are experts in display/screening/libraries methodologies, antibody engineering, and protein biochemistry, and a structural biologist. His major long-term goal is the development of clinically useful therapeutics and vaccines based on human monoclonal antibodies including engineered antibody domains.

Pierre A.Morgan

CEO, MRGN Advisors – Chairman, Virometix

Pierre A. MORGON is Chief Executive Officer of MRGN Advisors, a consultancy dedicated to the healthcare sector, and Regional Partner for Switzerland at Mérieux Développement, an evergreen investment structure focused on medical devices, in vitro diagnostics and patient management services.He is also holding the following board positions:Chairman of the Board of Virometix, a company developing proprietary synthetic nanoparticle platform in vaccines and immunotherapeutic drugs for viral diseases and cancer. Non-Executive Director to the Board of Theradiag, a company focusing on in vitro diagnostics in auto-immunity, infectious diseases and allergy, Non-Executive Director to the Board of Eurocine Vaccines, a company dedicated to developing intra nasal vaccines.He holds a Doctorate of Pharmacy, a Master in Business Law and a MBA. He is also an alumnus of INSEAD, IMD and MCE executive programs.

Michel H Klein

VaxiBio Inc, 54 Strathgowan Avenue,Toronto, Ontario,Canada.

M Klein is currently Chairman of VaxiBio Inc. He is a former Professor of Immunology at the University of Toronto and the former Corporate Vice-President Science and Technology at Aventis Pasteur (now Sanofi Pasteur)

Ljudmila Stojanovich

University Medical Center, Belgrade University, Serbia

Ljudmila Stojanovich received her Ph.D. in Medicine, with the thesis “Neuropsychiatric manifestations in patients with Systemic Lupus Erythematosus” in 1999. She is the scientific director in the Bezhanijska Kosa, University Medical Center of Belgrade University, where she is currently a Full Research Professor. Dr. Stojanovich’s research focuses on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, and Vaccination in patients with Autoimmune Rheumatic diseases. She is an author of three monographs and of about 250 articles on various aspects of Autoimmune Rheumatic disorders, published in international and domestic journals and in conference proceedings. She is in Editorial Boards (Editorial Boards LUPUS (LONDON). /Reviewer in the “CURRENT CONTENSTS” or “Science citation index”, like LUPUS REWIEWER DATABAS, Cellular and Molecular Neurobiology, The Journal of Vaccine

Gamal Ramadan Shebl Ramadan

Professor of Immunology, Ain Shams University, Cairo, Egypt

Gamal Ramadan Shebl Ramadan is a Professor of Immunology in the Zoology Department, Faculty of Science, Ain Shams University. He is in general specialty is Physiology and his specific and fine specialty is Molecular and Cellular Immunology.

Scientific Sessions

Virology Sessions

  • Current Trends and Research In Virology and Vaccines
  • Viral Breakout: Prevention and Measures
  • Diagnosis and Analysis of Viruses
  • Viral Immunology
  • Pediatrics Virology
  • Viral Therapy and Viral Vectors
  • Plant And Agricultural Virology
  • Veterinary and Animal Virology
  • Transplant associated Viral Infections
  • Anti Viral Agents and Treatments
  • Viral Transmission and Viral Epidemiology
  • Medical and Molcular Virology
  • Human Viruses in Water and Virus Pollution
  • Infectious Diseases-Treatment
  • Virotherapy

Vaccines Sessions

  • Infectious & Non-Infectious Diseases
  • Veterinary Vaccines
  • Therapeutic Vaccination
  • Influenza Vaccines/Virus
  • Biodenfense Vaccines
  • Cancer Vaccines
  • Passive Vaccines
  • Clinical Trials
  • Technologies, Bioprocessing & Manufacturing
  • New Vaccine Development
  • DNA Vaccines
  • Emerging and Re‐emerging Diseases
  • Vaccines Against Respiratory Pathogens
  • Vaccine Regulation

Registration Categories

Early Bird Date: 30 November 2017

Venue

Check out the Venue Information

London, UK
Get Direction